3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
19
Ovarian Neoplasms
17
Neuroblastoma
15
Fallopian Tube Neoplasms
13
Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Ganglioneuroblastoma
5
Brain Neoplasms
4
Uterine Cervical Neoplasms
3
Recurrence
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Glioma
3
Central Nervous System Neoplasms
3
Sarcoma, Ewing
2
Rhabdoid Tumor
2
Retinoblastoma
2
Medulloblastoma
2
Leukemia, Myeloid, Acute
2
Wilms Tumor
1
Thrombocythemia, Essential
1
SCLC, Extensive Stage
1
SCLC
1
Rhabdomyosarcoma
1
Retinal Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pleuropulmonary blastoma
1
Peritoneal Neoplasms
1
Pediatric Brain Tumor
1
Interventions
pembrolizumab
2
atezolizumab
2
Paclitaxel
2
Carboplatin
2
veliparib
1
sintilimab
1
pertuzumab
1
pemigatinib
1
olaparib
1
ivosidenib
1
ipatasertib
1
entrectinib
1
cobimetinib
1
alectinib
1
Whole Genome Sequencing
1
Vemurafenib
1
Transurethral Resection of Prostate
1
Taxes
1
Surveys and Questionnaires
1
Specimen Handling
1
Sequence Analysis, RNA
1
Radiosurgery
1
Magnetic Resonance Spectroscopy
1
HhAntag691
1
Genetic Testing
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Erlotinib Hydrochloride
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Unknown Primary
×
Topotecan
×
1 year
×
Clear all
No trials found.